Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
Proton pump inhibitors (PPIs) are the most potent drugs for reducing gastric acid secretion; so, since their release in the late 1980s, they have been recommended as the first therapeutic choice for many gastroesophageal diseases, risk reduction in or healing of non-steroidal anti-inflammatory drugs...
Main Author: | Mario Visconti |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2015-09-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | http://www.italjmed.org/index.php/ijm/article/view/562 |
Similar Items
-
Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01) -
Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01) -
A dual role of proton pump inhibition on cancer: a critical review
by: Edizer Deniz Tuna, et al.
Published: (2023-02-01) -
Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics
by: Mária Matuz, et al.
Published: (2020-09-01) -
Proton Pump Inhibitors: Are They a Real Threat to the Patient?
by: Sofia Xavier, et al.
Published: (2018-02-01)